A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines.

NCT05046522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Palmitoylethanolamide sold as Levagen +
DRUG: Placebo comparator - maltodextrin and microcrystalline cellulose mix

Sponsor

RDC Clinical Pty Ltd